Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis

Advances in Rheumatology - Tập 58 Số 1 - Trang 1-10 - 2018
Lomonte, Andrea Barranjard Vannucci1, Mendonça, José Alexandre2, de Castro Brandão, Gilberto3, Castro, Marise Lazaretti4
1Centro Paulista de Investigação Clínica (CEPIC), São Paulo, Brazil
2Instituto de Pesquisa Clínica e Assistência Médica de Campinas (IPECC), Campinas, Brazil
3Clínica Perdizes, São Paulo, Brazil
4Instituto de Pesquisa Clínica e Medicina Avançada (IMA), São Paulo, Brazil

Tóm tắt

To compare the efficacy and safety of a new fixed dose combination of glucosamine sulfate and chondroitin sulfate capsules (GS/CS) versus the fixed dose combination of glucosamine hydrochloride and chondroitin sulfate (Cosamin DS®) in capsules in patients with osteoarthritis (OA) of the knee. Multicenter, randomized, double-blind study. Participants with knee OA Kellgren-Lawrence grades 1 to 3 and VAS of symptoms ≥4 cm were randomized to receive GS/CS or Cosamin DS® over 12 weeks. The primary efficacy endpoint was the evaluation of the analgesic efficacy by the investigator. Secondary efficacy endpoints included: joint pain and swelling, investigator efficacy of the medication, and the use of rescue medication. Adverse events and drug tolerability were analyzed. One hundred patients were randomized, and 50 patients were allocated to each group. The analgesic efficacy evaluated by the investigator in the GS/CS group was 88.9, 95%CI: 75.2, 95.8% and in the Cosamin DS® group was 85.4%; 95%CI: 70.1, 93.4%. The mean reduction in the pain intensity was significant in both groups (p < 0.001), with no difference between them. The primary efficacy analysis demonstrated the non-inferiority of the GS/CS group compared with the Cosamin DS® group; the lower limit of the 90% confidence interval (CI) between the two groups (− 8.39%) was higher than the established margin of non-inferiority of − 10.00%. Improvement in other efficacy outcomes was observed, again without differences between groups. Adverse events were similar between groups and both presented good tolerability. The new fixed-dose formulation of GS/CS is effective in treating knee OA, presenting a good safety and tolerability profile. ( https://clinicaltrials.gov/ct2/show/NCT00955552?term=NCT00955552&rank=1 ; ClinicalTrials.gov ; register number NCT00955552; First randomized patient: 08/17/2010).

Tài liệu tham khảo

citation_journal_title=Part II Arthritis Rheum; citation_title=Estimates of the prevalence of arthritis and other rheumatic conditions in the United States; citation_author=RC Lawrence, DT Felson, CG Helmick, LM Arnold, H Choi, RA Deyo, S Gabriel, R Hirsch, MC Hochberg, GG Hunder, JM Jordan, JN Katz, HM Kremers, F Wolfe; citation_volume=58; citation_issue=1; citation_publication_date=2008; citation_pages=26-35; citation_doi=10.1002/art.23176; citation_id=CR1 citation_journal_title=Lancet; citation_title=Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010; citation_author=T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati; citation_volume=380; citation_issue=9859; citation_publication_date=2012; citation_pages=2163-2196; citation_doi=10.1016/S0140-6736(12)61729-2; citation_id=CR2 citation_journal_title=Open Orthop J; citation_title=Quality of life in patients with knee osteoarthritis: a commentary on nonsurgical and surgical treatments; citation_author=J Farr Ii, LE Miller, JE Block; citation_volume=7; citation_publication_date=2013; citation_pages=619-623; citation_doi=10.2174/1874325001307010619; citation_id=CR3 citation_journal_title=Arthritis Rheum; citation_title=An update on the epidemiology of knee and hip osteoarthritis with a view to prevention; citation_author=DT Felson, Y Zhang; citation_volume=41; citation_issue=8; citation_publication_date=1998; citation_pages=1343-1355; citation_doi=10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; citation_id=CR4 citation_journal_title=Arthritis Rheum; citation_title=Lifetime risk of symptomatic knee osteoarthritis; citation_author=L Murphy, TA Schwartz, CG Helmick, JB Renner, G Tudor, G Koch, A Dragomir, WD Kalsbeek, G Luta, JM Jordan; citation_volume=59; citation_issue=9; citation_publication_date=2008; citation_pages=1207-1213; citation_doi=10.1002/art.24021; citation_id=CR5 citation_journal_title=Rev Bras Reumatol; citation_title=Consenso brasileiro para o tratamento da osteoartrite (artrose); citation_author=IB Coimbra, EH Pastor, JMD Greve, MLC Puccinelli, R Fuller, FS Cavalcanti, FMB Maciel, E Honda; citation_volume=42; citation_issue=6; citation_publication_date=2002; citation_pages=371-374; citation_id=CR6 citation_journal_title=Pol Arch Med Wewn; citation_title=Balancing cardiovascular and gastrointestinal risks in patients with osteoarthritis receiving nonsteroidal anti-inflammatory drugs; citation_author=W Mosleh, ME Farkouh; citation_volume=126; citation_issue=1–2; citation_publication_date=2016; citation_pages=68-75; citation_id=CR7 citation_journal_title=Semin Arthritis Rheum; citation_title=A systematic review of recommendations and guidelines for the management of osteoarthritis: the chronic osteoarthritis management initiative of the U.S. bone and joint initiative; citation_author=AE Nelson, KD Allen, YM Golightly, P Goode, JM Jordan; citation_volume=43; citation_issue=6; citation_publication_date=2014; citation_pages=701-712; citation_doi=10.1016/j.semarthrit.2013.11.012; citation_id=CR8 citation_journal_title=J Pharm Pharmacol; citation_title=Quality of different chondroitin sulfate preparations in relation to their therapeutic activity; citation_author=N Volpi; citation_volume=61; citation_issue=10; citation_publication_date=2009; citation_pages=1271-1280; citation_doi=10.1211/jpp.61.10.0002; citation_id=CR9 citation_journal_title=J Rheumatol; citation_title=Active ingredient consistency of commercially available glucosamine sulfate products; citation_author=AS Russell, A Aghazadeh-Habashi, F Jamali; citation_volume=29; citation_issue=11; citation_publication_date=2002; citation_pages=2407-2409; citation_id=CR10 citation_journal_title=Curr Med Res Opin; citation_title=Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis; citation_author=JY Reginster, C Cooper, M Hochberg, JP Pelletier, R Rizzoli, J Kanis, E Abadie, E Maheu, ML Brandi, JP Devogelaer, J Branco, G Herrero-Beaumont, P D’Hooghe, O Bruyère; citation_volume=31; citation_issue=5; citation_publication_date=2015; citation_pages=1041-5; citation_doi=10.1185/03007995.2015.1027183; citation_id=CR11 citation_journal_title=Arthritis Care Res (Hoboken); citation_title=American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip and knee; citation_author=MC Hochberg, RD Altman, KT April, M Benkhalti, G Guyatt, J McGowan, T Towheed, V Welch, G Wells, P Tugwell; citation_volume=64; citation_publication_date=2012; citation_pages=465-474; citation_doi=10.1002/acr.21596; citation_id=CR12 citation_journal_title=Osteoarthr Cartil; citation_title=OARSI guidelines for the non-surgical management of knee osteoarthritis; citation_author=TE McAlindon, RR Bannuru, MC Sullivan, NK Arden, F Berenbaum, SM Bierma-Zeinstra, GA Hawker, Y Henrotin, DJ Hunter, H Kawaguchi, K Kwoh, S Lohmander, F Rannou, EM Roos, M Underwood; citation_volume=22; citation_issue=3; citation_publication_date=2014; citation_pages=363-388; citation_doi=10.1016/j.joca.2014.01.003; citation_id=CR13 citation_journal_title=Semin Arthritis Rheum; citation_title=A consensus statement on the European Society for Clinical and Economic Aspects of osteoporosis and osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis – from evidence-based medicine to the real-life setting; citation_author=O Bruyere, C Cooper, JP Pelletier, E Maheu, F Rannou, J Branco, M Luisa Brandi, JA Kanis, RD Altman, MC Hochberg, J Martel-Pelletier, JY Reginster; citation_volume=45; citation_issue=4 Suppl; citation_publication_date=2016; citation_pages=S3-11; citation_doi=10.1016/j.semarthrit.2015.11.010; citation_id=CR14 citation_journal_title=Osteoarthr Cartil; citation_title=Efficacy of a combination of FCHG49™ glucosamine hydrochloride, TRH122™ low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis; citation_author=A Das, TA Hammad; citation_volume=8; citation_issue=5; citation_publication_date=2000; citation_pages=343-350; citation_doi=10.1053/joca.1999.0308; citation_id=CR15 citation_title=Practical statistics for medical research; citation_publication_date=1991; citation_id=CR16; citation_author=D Altman; citation_publisher=Chapman & Hall/ CRC Kellner, S. R. O. Estatística sem mistérios. Volume I, segunda edição. Editora Vozes, p. 433–434. citation_journal_title=BMJ; citation_title=Effects of glucosamine, chondroitin, or placebo in patients with osteoartrhtis of hip or knee: network meta-analysis; citation_author=S Wandel, P Jüni, B Tendal, E Nüesch, PM Villiger, NJ Welton, S Reichenbach, S Trelle; citation_volume=341; citation_publication_date=2010; citation_pages=C4675; citation_doi=10.1136/bmj.c4675; citation_id=CR18 citation_journal_title=Sci Rep; citation_title=Effectiveness and safety of glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of knee; citation_author=C Zeng, J Wei, H Li, YL Wang, DX Xie, T Yang, SG Gao, YS Li, W Luo, GH Lei; citation_volume=5; citation_publication_date=2015; citation_pages=16827; citation_doi=10.1038/srep16827; citation_id=CR19 citation_journal_title=Ann Rheum Dis; citation_title=Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib; citation_author=MC Hochberg, J Martel-Pelletier, J Monfort, I Möller, JR Castillo, N Arden, F Berenbaum, FJ Blanco, PG Conaghan, G Doménech, Y Henrotin, T Pap, P Richette, A Sawitzke, P Souich, JP Pelletier; citation_volume=75; citation_issue=1; citation_publication_date=2016; citation_pages=37-44; citation_doi=10.1136/annrheumdis-2014-206792; citation_id=CR20 citation_journal_title=Osteoarthr Cartil; citation_title=Total joint replacement after glucosamine sulfate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from previous 3-year, randomised, placebo-controlles trials; citation_author=O Bruyere, K Pavelka, LC Rovati, J Gatterová, G Giacovelli, M Olejarová, R Deroisy, JY Reginster; citation_volume=16; citation_issue=2; citation_publication_date=2008; citation_pages=254-260; citation_doi=10.1016/j.joca.2007.06.011; citation_id=CR21 citation_journal_title=Osteoarthr Cartil; citation_title=The effects of oral glucosamine on joint health: is a change in research approach needed?; citation_author=JA Block, TR Oegema, JD Sandy, A Plaas; citation_volume=18; citation_issue=1; citation_publication_date=2010; citation_pages=5-11; citation_doi=10.1016/j.joca.2009.07.005; citation_id=CR22